The PennZone

CARTHAGE, Mo. - PennZone -- Stratum Nutrition is pleased to announce that ESM Technologies, LLC recently received Notices of Allowance for two different patents in two new geographic regions.

One of the patents, 'Methods for Treating NF-kB Dysregulation in a Host in Need Thereof Using Eggshell Membrane Compositions' was first issued in the U.S. in 2019 (US 10,328,104) and has recently been allowed by the European Patent Office.  This invention deals with a whole host of conditions and diseases related to NF-kB dysregulation including: pulmonary, gastrointestinal, cardiovascular, & nervous system.

The other patent, 'Method for Evaluating Articular Joint Therapeutics' was first issued in the U.S. in 2018 (US 9,983,214) and has recently been allowed by the Canadian Intellectual Property Office.  This invention deals with a clinical trial design using the cartilage degradation biomarker CTX-II to evaluate articular joint therapeutics for chondroprotective efficacy.  Both patents are still pending in multiple additional jurisdictions.

"We are excited to extend our patent protection to additional geographies.  This is particularly true for our CTX-II clinical model patent, which has now been allowed in the U.S., Europe, Canada, Japan, and several other countries.  We have used this patented model in multiple clinical trials to demonstrate that our flagship ingredient, NEM® brand eggshell membrane, helps to protect cartilage in exercising individuals.", said Kevin Ruff, Stratum's Sr. Director of Scientific & Regulatory Affairs.

More on The PennZone

• Scott Ritsema of Bisnar Chase Selected for 2026 National Traumatic Brain Injury Association
• Flint Youth Film Festival Shifts Gears, Becomes Vehicle City Film Festival
• 62% of Gen X have no estate planning documents — Trust & Will research identifies "the Sandwich Gap"
• Nayarit's Jungle Coast Redefines Luxury Travel on Mexico's Pacific Now More Accessible Than Ever
• $10 Million Annual Revenue Merger, Profitable Partner in AI Powered Specialty Automotive Sales Projected to Scale Above $200M: Stock Symbol: NWPG

For more information about Stratum Nutrition^® and its branded ingredients, please visit www.stratumnutrition.com.

###

About Stratum Nutrition

Stratum Nutrition^®, a business of ESM Technologies, LLC, sustainably provides world class nutrition ingredient solutions to nutritional product formulators for human and pet health. Stratum offers a portfolio of research-supported, branded ingredients that are progressive, safe and effective, including NEM^® brand eggshell membrane, ESC^® brand eggshell calcium, Ahiflower^® plant-based omegas-3,6,9, Curcumin 95, curQplus™, LBiome™ Lactobacillus LB postbiotic, NatAxtin™ astaxanthin, as well as oral health probiotics, BLIS K12^® and BLIS M18^®. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.